Evaluation of Using Patient Specific Zirconium Dioxide Implant Versus Patient Specific Titanium Implant in Treatment of Chronic Condylar Dislocation
Evaluation of Using Patient Specific Zirconium Dioxide Implant Versus Patient Specific Titanium Implant in Treatment of Chronic Condylar Dislocation. A Randomized Clinical Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Adham Yehia Zakaria, Master
- Phone Number: 002 01226000564
- Email: adham.zakaria@dentistry.cu.edu.eg
Study Contact Backup
- Name: Amira Yehia Zakaria, Bachelor
- Phone Number: 002 01226000741
- Email: amira_5queens@hotmail.com
Study Locations
-
-
-
Cairo, Egypt
- Adham Zakaria
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient with recurrent dislocation with maximum inter incisal opening over 55mm
- Long-standing dislocation of the TMJ involving both fixation for more than 3 weeks and the failure of manual reduction
- Failure of conservative strategies such as orientation to self-limit jaw movement and the use of a chin-cap or bandage
- Both sexes
- Age between 18 and 48 years.
- Highly motivated patients.
Exclusion Criteria:
- Post-menopausal females with osteoporosis
- Patient with uncontrolled systemic disease
- pregnancy
- psychological disorders, drug or alcohol dependency
- Known allergies or sensitivities to dental materials, including Zirconia, Titanium or general anesthetic agents
- Inability to return for follow up visits.
- Refusal of participation from the patient
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: eminoplasty with patient specific Titanium onlay implant
|
Eminoplasties will be done for patient with chronic condylar dislocation using patient specific zirconium dioxide implants
|
|
Active Comparator: eminoplasty with patient specific zirconium dioxide onlay implant
|
Eminoplasties will be done for patient with chronic condylar dislocation using patient specific zirconium dioxide implants
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in Maximal inter incisal distance between pre-operative and post-operative (mm)
Time Frame: 6 months
|
using a caliper the difference between preoperative and postoperative Maximal interincisal opening is recorded (mm)
|
6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient's Pain
Time Frame: 6 months
|
in terms of visual analogue scale (0-10)
|
6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Mohammed Kadry Nasr, Doctorate, Lecturer at Oral and Maxillofacial Surgery department, Faculty of dentistry, Cairo University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- OMFS 3-3-4
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.